Diversity in the administration of antibiotics in German intensive care units;Diversität des antibiotikaverbrauchs auf intensivstationen in Deutschland

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 6, 2008, Pages 235-240

  Meyer, E ^a   Schwab, F ^b,c   Schroeren Boersch, B ^a   Ruden H ^b,c   Gastmeier, P ^d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Nationales Referenzzentrum für Surveillance Nosokomialer Infektionen ^*

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Antibiotic prescribing parameters; Antibiotic use; Intensive care units

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; CARBAPENEM; CEPHALOSPORIN; GLYCOPEPTIDE; IMIDAZOLE; MACROLIDE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE; ANTIINFECTIVE AGENT;

ANTIBIOTIC USAGE DENSITY; ARTICLE; DEFINED DAILY DOSAGE; DENSITY; DOSE CALCULATION; DRUG ADMINISTRATION; DRUG USE; HUMAN; INTENSIVE CARE UNIT; PARAMETER; PHARMACY; PRESCRIPTION; DRUG EFFECT; DRUG RESISTANCE; EPIDEMIOLOGY; GERMANY; HEALTH CARE QUALITY; HEALTH SURVEY; LENGTH OF STAY; RISK FACTOR; STANDARD; STATISTICS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE; DRUG UTILIZATION REVIEW; GERMANY; HEALTH CARE SURVEYS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; QUALITY INDICATORS, HEALTH CARE; RISK FACTORS; SENTINEL SURVEILLANCE;

EID: 39549103696     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1017502     Document Type: Article

References (16)

1. Archibald L et al. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-215
2. Bergstrom CT et al. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci U S A 2004; 101: 13 285-13 290
3. Council recommendation on the prudent use of antimicrobial agents in human medicine. Official Journal of the European Communities (2002/77/EC) 2002, L 34-13-L 34/16
4. de With K et al. Antibiotic use in Germany and European comparison. Dtsch Med Wochenschr 2004; 129: 1987-1992
5. Fridkin SK et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29: 245-252
6. Goossens H et al. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin Infect Dis 2007; 44: 1091-1095
7. Hanberger H et al. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period. Acta Anaesthesiol Scand 2007; 51: 937-941
8. Kresken M et al. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Antiinfective Intelligence 2004; Bonn: 1-89
9. Levin BR, Bonten MJ. Cycling antibiotics may not be good for your health. Proc Natl Acad Sci U S A 2004; 101: 13101-13102
10. Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 2003; 36 (Suppl 1): S11-S23
11. MacKenzie FM et al. Relationship between the number of different antibiotics used and the total use of antibiotics in European hospitals. J Antimicrob Chemother 2006; 58: 657-660
12. Meyer E et al. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced. J Antimicrob Chemother 2007; 59: 148-1854
13. Meyer E et al. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive Care units (SARI). Infection 2003; 31: 208-215
14. Meyer E et al. Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units. Intensive Care Med 2004; 30: 1089-1096
15. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004. Am J Infect Control 2004; 32: 470-485
16. World Health Organisation. WHO Global Strategy for Containment of Antimicrobial Resistance. 2005